10,209
Total Claims
$2.6M
Drug Cost
974
Beneficiaries
$2,712
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
+78%
Cost per patient vs peers
$2,712 vs $1,524 avg
+54%
Brand preference vs peers
21.0% vs 13.7% avg
Brand vs Generic
79% generic
Brand: 2,142 claims · $2.4M
Generic: 8,067 claims · $272K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 533 | $570K |
| Rivaroxaban | 443 | $471K |
| Sacubitril/Valsartan | 233 | $369K |
| Riociguat | 21 | $249K |
| Dronedarone Hcl | 108 | $145K |
| Empagliflozin | 52 | $84K |
| Vericiguat | 59 | $67K |
| Dapagliflozin Propanediol | 33 | $49K |
| Icosapent Ethyl | 123 | $42K |
| Evolocumab | 35 | $40K |
| Metoprolol Succinate | 1,608 | $39K |
| Midodrine Hcl | 210 | $32K |
| Ticagrelor | 47 | $32K |
| Pitavastatin Calcium | 35 | $31K |
| Azilsartan Medoxomil | 60 | $29K |
Prescribing Profile
75
Unique Drugs
$1.5M
Patient Profile
73
Avg Age
60%
Female
1.92
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data